Steroids: First Line Treatment in Pediatrics
dc.contributor.author | Spier, Sheldon | |
dc.date.accessioned | 2018-09-27T12:30:50Z | |
dc.date.available | 2018-09-27T12:30:50Z | |
dc.date.issued | 1995-01-01 | |
dc.date.updated | 2018-09-27T12:30:50Z | |
dc.description.abstract | The benefits derived from the use or inhaled steroids in pediatric asthma are reviewed in relation to the age of the patient, the delivery system and the compliance versus frequency of administration of these medications. Side effects are discussed with regard to the age or the child and the following systems: the eyes, the skin, the oropharynx, the voice, the immune system, lipid and carbohydrate metabolism,adrenal glands, bone metabolism and growth. | |
dc.description.version | Peer Reviewed | |
dc.identifier.citation | Sheldon Spier, “Steroids: First Line Treatment in Pediatrics,” Canadian Respiratory Journal, vol. 2, no. Suppl A, pp. 13A-18A, 1995. doi:10.1155/1995/878063 | |
dc.identifier.doi | https://doi.org/10.1155/1995/878063 | |
dc.identifier.uri | http://hdl.handle.net/1880/108650 | |
dc.identifier.uri | https://doi.org/10.11575/PRISM/45390 | |
dc.language.rfc3066 | en | |
dc.rights.holder | Copyright © 1995 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
dc.title | Steroids: First Line Treatment in Pediatrics | |
dc.type | Journal Article |